For years, Elon Musk has dreamed of conquering a range of chronic health conditions by inserting computer chips into the human brain. But that vision could become reality fastest in China, where state authorities are launching a coordinated effort to accelerate the nascent industry’s development.The past few days have seen a string of initiatives related to brain-computer interfaces (BCIs) announced in China, involving parties ranging from state insurance companies to investment banks and local governments.On Wednesday, PICC Property and Casualty – a major state-owned insurer – announced it had signed the nation’s first commercial insurance policy covering the invasive surgery often needed to implant a BCI in a patient’s brain.The news sent ripples through the markets, with BCI-linked stocks in Hong Kong climbing as investors bet the insurance breakthrough would help speed up the technology’s commercialisation.Shares of BCI-related companies rose by 1.59 per cent on Wednesday. Shanghai Heartcare Medical Technology, a maker of neuro-interventional medical devices, was up 1.28 per cent, while software developer BrainAurora Medical Technology rose 1.65 per cent.PICC Property and Casualty has launched its scheme in partnership with a hospital affiliated with the Zhejiang University School of Medicine in Hangzhou, a tech hub in eastern China home to leading start-ups including AI firm DeepSeek and humanoid robot pioneer Unitree Robotics.
The next tech race? China launches push to leapfrog US in ‘brain chip’ devices
China is throwing the power of the state behind efforts to overtake Elon Musk in a vital frontier technology: brain-computer interfaces.
China's state insurer PICC issued the first commercial BCI-implant insurance; stocks surged 1.59%, signaling acceleration. Removing adoption friction positions China to leapfrog US in neural devices—Western incumbents must accelerate neurotec investment or cede market leadership.







